El Fortalecimiento de los Derechos Forestales Comunitarios es una Herramienta Fundamental para Luchar Contra el Cambio Climático, Indica un Nuevo e Importante Informe

El fortalecimiento de los derechos forestales comunitarios es una estrategia esencial para reducir los miles de millones de toneladas de emisiones de carbono, haciéndolo una forma efectiva para que los gobiernos cumplan los objetivos climáticos, salvaguarden los bosques y protejan las subsistencias de sus ciudadanos, según un importante reporte nuevo. El informe, llamado "Asegurando derechos, luchando contra el cambio climático: Cómo el fortalecimiento de los derechos forestales comunitarios mitiga el cambio climático", está siendo publicado conjuntamente por el Instituto de Recursos Mundiales (World Resources Institute - WRI) y la Iniciativa Derechos y Recursos (Rights and Resources Initiative - RRI). El documento proporciona el análisis más completo a la fecha vinculando el reconocimiento legal y la protección gubernamental de los derechos forestales comunitarios junto con las reducciones en la contaminación de carbono.

– World Resources Institute (WRI) and Rights and Resources Initiative (RRI)|23-Jul-2014 8:00 PM EDT

Strengthening Community Forest Rights is Critical Tool to Fight Climate Change, Says Major New Report

Strengthening community forest rights is an essential strategy to reduce billions of tonnes of carbon emissions, making it an effective way for governments to meet climate goals, safeguard forests and protect the livelihoods of their citizens, according to a major new report. The report, called “Securing Rights, Combating Climate Change: How Strengthening Community Forest Rights Mitigates Climate Change,” is being published jointly by World Resources Institute (WRI) and Rights and Resources Initiative (RRI). The paper provides the most comprehensive analysis to date linking legal recognition and government protection of community forest rights with reductions in carbon pollution.

– World Resources Institute (WRI) and Rights and Resources Initiative (RRI)|23-Jul-2014 8:00 PM EDT

UAB Enrolls Nation’s First Patient in Phase III Drug Trial for Preeclampsia

UAB has enrolled the first patient in the United States in a Phase III clinical trial for a drug to treat preeclampsia in pregnant women that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality.

– University of Alabama at Birmingham|23-Jul-2014 5:20 PM EDT

Penn Study Reveals New Evidence Showing Medical Student Perceptions of Health Policy Education are Improving, but 40 Percent are Still Not Satisfied

Students graduating from U.S. medical schools in 2012 feel they’ve received a better education in health policy issues than graduates surveyed in 2008, according to a multi-center study led by the Perelman School of Medicine at the University of Pennsylvania, and published online this month in Academic Medicine. The study applied a new framework for teaching and evaluating perceptions of training in health policy, first proposed by the authors in a 2011 perspective published in the New England Journal of Medicine.

– Perelman School of Medicine at the University of Pennsylvania |23-Jul-2014 4:45 PM EDT

Is Your Data Safe? Why You Should Care More About Spam

Researchers are working to protect consumer data by using companies spam volume to evaluate its security vulnerability through the SpamRankings.net project.

– University of Texas at Austin|23-Jul-2014 4:00 PM EDT

Drug Approved to Treat Rare Disorder Associated with Anesthesia

henry-rosenberg.jpg

Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures. MH is an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible individuals. FDA had designated Ryanodex as an Orphan Drug in August 2013. Eagle has been informed by the FDA that it will learn over the next four to six weeks if it has been granted the seven year Orphan Drug market exclusivity.

– Malignant Hyperthermia Association of the United States (MHAUS)|23-Jul-2014 4:00 PM EDT

Monitoring Pulse After Stroke May Prevent a Second Stroke

New research suggests that regularly monitoring your pulse after a stroke or the pulse of a loved one who has experienced a stroke may be a simple and effective first step in detecting irregular heartbeat, a major cause of having a second stroke. The study is published in the July 23, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

– American Academy of Neurology (AAN)|23-Jul-2014 4:00 PM EDT

How Honey Bees Stay Cool

starksandhoneybees.jpg

Research also supports the theoretical construct of the bee hive as a superorganism—an entity in which its many members carry out specialized and vital functions to keep the whole functioning as a unit.

– Tufts University|23-Jul-2014 3:00 PM EDT
  • “The attendance at this year’s Airline Quality Rating event was the most we’ve had in a number of years, with about 10 TV cameras at the news conference.... We were extremely pleased with the turnout. It is a pleasure working with you and the Newswise staff. They are most helpful!more >>

    —Joe Kleinsasser, Wichita State University

  • “I do follow your regularly e-mailed announcements of press releases and, as a medial journalist, I find them of great value.  The announcements regularly lead me to items of interest, which I report on in our Pain-Topics News/Research UPDATES. more >>

    —Reporter

  • “Release on cellphones and radiation exposure gains major news coverage.

    more >>

    —Environmental Health Trust

  • “Seven years later I still am getting coverage for a story on contaminated makeup counters that I pitched in 2004. At the time we had more than 100 hits around the globe, in places I never could have reached without spending weeks with directories, web searches and emails. Newswise enabled me to reach reporters and outlets I could only dream about: CNN and 20/20 covered the story, as did...more >>

    —Pat Quigley, Rowan University

  • “ I love the ease and convenience of scanning the Newswise digests. I can quickly find exactly what I need: the newest research studies....What's more, the neuroscientists I found from Newswise press releases took starring roles in my latest book, Brain Sense.more >>

    —Faith Byrnie, Book Author and Freelance Journalist

  • “I use it all the time.more >>

  • “Your service is great! more >>

  • “I sent out a request for expert input through Newswise and got a very impressive response from a wide spectrum of experts who offered themselves as expert interview subjects.... I think it's a great enhancement to any reporter's search for sources and information. more >>

    —Freelance Reporter

  • “I definitely find Newswise valuable and use it quite often to search for studies or find experts. more >>

    —Freelance Reporter

  • “Newswise is one of my absolute favorite vehicles for getting media attention. It is so user-friendly to enter (and edit) stuff; you all are incredibly helpful; the format of Newswise looks professional; and it clearly has a wider audience (and more respect) than other vehicles.more >>

    —Terry Goodrich, Baylor University

  • “Using Newswise, I was able to reach the target media instantly and gain some nice national media placements as well as placements on key websites and blogs. The story landed 25 placements, something that pleased me and the researchers.more >>

    —Bill Harms, University of Chicago

  • “Your service is one of the most dependable and reliable out there. The bonus is that the content is rich, timely and oh-so useful.more >>

    —Freelance Journalist

  • “The easy access, patient and incredibly helpful customer support we receive from Newswise staff is the real hallmark of Internet-based service in today's fast-paced, communication world. more >>

    —Jeannie Jones Manzer, South Dakota State University

  • “As an independent public relations professional, I rely on the knowledge that when a medical/health writer sees the Newswise name, they know the content they’re receiving will be relevant and timely.more >>

    —Leni Kass, RealTime Communications

  • “We received quite a number of Newswise Wire follow-up calls. Most lead to stories by reporters....A significant portion of response from reporters came from Newswise via the ATS meeting wire. That was a huge outreach.more >>

    —Keely Savoie, American Thoracic Society (ATS)

  • “In total, at least 29 sources either republished the "No Soap" story ...that we posted on Newswise.more >>

    —Holly Hosler, LifeBridge Health

  • “I find Newswise especially helpful in reaching bloggers, who are difficult to find, often too numerous to pitch individually and whose contact information is rarely made public. One recent story about a business professor who studies fantasy football was featured in 10 or 12 blogs about fantasy sports, none of which I even knew existed. Another example was a blogger for MSNBC.com who saw...more >>

    —Tom Snee, University of Iowa

  • “I use Newswise now on a weekly basis to develop possible stories for the Harvard Health Blog, which is one of my duties. I find it very useful, and am grateful for the service you provide—and you can quote me on that!more >>

    —Staff Reporter

  • “Love the idea that now I can find the title via google!!! All in one place!! Nice move!more >>

    —Janet Vasquez, Business School of Happiness

  • “As a PR/communications professional it is reassuring to work with an organization like Newswise. You folks are great!more >>

    —Phyllis Edelman, Genetics Society of America

Previous commentNext comment

Cancer News Source is a Newswise initiative to promote cancer research news to the public and news media.

Newswise is where journalists choose, connect, and use smart news.

Journalists use Newswise as a source for news leads and experts from the world’s leading organizations. Members of the media can get a PressPass for access to privileged Embargoed News and expert contact information.

Newswise members use Newswise to reach the media with their news releases through our website and email wires. Members are innovative, influential organizations world-wide, including top medical schools, universities, research institutions, public relations firms, government agencies, non-profit organizations, associations and advocacy groups.

Anyone interested in knowledge-based news can register for Newswise and subscribe to the email wires.

Read more about Newswise

Find out about membership opportunities

Follow us On the Web

Facebook Twitter LinkedIn Stumbleupon

Join our LinkedIn group for communications professionals:

PRwise

Submission Deadline
 
7/22/14
Cancer Research
7/28/14
Obesity
7/29/14
Environment and Climate Change